Repérage et traitement de la dépression en cancérologie

Depression in cancer patients: how to detect and manage it

Résumé

Alors que la dépression représente une pathologie fréquente chez les patients atteints de cancer, dont les répercussions sont multiples en termes de qualité de vie, mais aussi en termes de survie, du fait des inégalités d’accès aux soins et de traitement dont elle peut être la cause, elle est encore souvent sous-estimée et non diagnostiquée. La bonne connaissance de la clinique dépressive, de sa prévalence et de ses facteurs de risque constitue le garant d’une prise en charge appropriée. Celle-ci passe souvent par la combinaison d’une approche pharmacologique et d’une approche psychothérapeutique. La sensibilisation des professionnels de la cancérologie au dépistage des éléments qui peuvent orienter vers un trouble dépressif et préciser le diagnostic est indispensable pour que chaque patient déprimé ait accès à des soins adéquats.

Abstract

Despite its high prevalence and clear impact on patients’ quality of life as well as on survival and inequalities to care and access to care, depression continues to be underdiagnosed and inadequately treated in the context of cancer. A better knowledge of depressive clinical manifestations and of its prevalence and risk factors is a key entry for a better managed care. Treating depression commonly integrates a psychotropic and psychotherapeutic approach. Sensibilization of all health professionals is required to improve screening of depression in the cancer setting, which will give access to the appropriate care for each depressed cancer patient.

This is a preview of subscription content, log in to check access.

Références

  1. 1.

    Akechi T, Okamura H, Nakano T, et al (2000) Suicidal ideation in cancer patients with major depression. Jpn J Clin Oncol 30(5): 221–224

    PubMed  Article  Google Scholar 

  2. 2.

    American Psychiatric Association (1994) Diagnostic and statistical manual of mental Disorders (DSM IV-R). Fourth Edition Revised, American Psychiatric Association, Washington, DC

    Google Scholar 

  3. 3.

    Blake-Mortimer J, Gore-Felton C, Kimerling R, et al (1999) Improving the quality and quantity of life among patients with cancer: a review of the effectiveness of group psychotherapy. Eur J Cancer 35:1581–1586

    PubMed  Article  Google Scholar 

  4. 4.

    Boesen EH, Johansen C (2008) Impact of psychotherapy on cancer survival: time to move on? Curr Opin Oncol 20:372–377

    PubMed  Article  Google Scholar 

  5. 5.

    Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med, 352:1112–1120

    PubMed  Article  Google Scholar 

  6. 6.

    Brédart A, Dolbeault S, Razavi D (2009) Psycho-oncology. In: World Cancer Report 2008 of IARC (International Agency for Research on Cancer) 1(9):74–83 (http://www.iarc.fr/en/publications/pdfs-online/wcr/)

    Google Scholar 

  7. 7.

    Brintzenhofe-Szoc KM, Levin TT, Li Y, et al (2009) Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 50:383–391

    PubMed  Article  Google Scholar 

  8. 8.

    Carlson LE, Bultz BD (2004) Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psycho-oncology 13:837–849

    PubMed  Article  Google Scholar 

  9. 9.

    Chiles J, Lambert M, Hatch A (1999) The impact of psychological interventions on medical cost offset: a meta-analytic review. Clin Psych Sci Pract 6:204–220

    Article  Google Scholar 

  10. 10.

    Chochinov H (2001) Depression in cancer patients. Lancet Oncol 2:499–505

    PubMed  Article  Google Scholar 

  11. 11.

    Ciaramella A, Poly P (2001) Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psychooncology 10:156–165

    PubMed  Article  Google Scholar 

  12. 12.

    Cipriani A, Barbui C, Salanti G, et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746–758

    PubMed  Article  Google Scholar 

  13. 13.

    Colleoni M, Mandala M, Perruzzoti G, et al (2000) Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 356:1326–1327

    PubMed  Article  Google Scholar 

  14. 14.

    Coogan P (2006) Review of 2000 the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurother 6:1363–1374

    PubMed  Article  Google Scholar 

  15. 15.

    Costanzo ES, Lutgendorf SK, Mattes ML, et al (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 97:1625–1631

    PubMed Central  PubMed  Article  Google Scholar 

  16. 16.

    Dalton SO, Schüz J, Engholm G, et al (2008) Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: summary of findings. Eur J Cancer 44:2074–2085

    PubMed  Article  Google Scholar 

  17. 17.

    Ell K, Sanchez K, Vourlekis B, et al (2005) Depression, correlates of depression, and receipt of depression care among lowincome women with breast or gynecologic cancer. J Clin Oncol 23:3052–3060

    PubMed Central  PubMed  Article  Google Scholar 

  18. 18.

    Ell K, Xie B, Quon B, et al (2008) Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 26:4488–4496

    PubMed  Article  Google Scholar 

  19. 19.

    Fann JR, Thomas-Rich AM, Katon WJ, et al (2008) Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 30:112–126

    PubMed  Article  Google Scholar 

  20. 20.

    Fisch M (2004) Treatment of depression in cancer. J Natl Cancer Inst Monogr 32:105–111

    PubMed  Article  Google Scholar 

  21. 21.

    Gagliese L, Gauthier LR, Rodin G (2007) Cancer pain and depression: a systematic review of age-related patterns. Pain Res Manage 12:205–211

    Google Scholar 

  22. 22.

    Gilbody S, Bower P, Fletcher J, et al (2006) Collaborative care for depression: a cumulative meta-analysis and review of longerterm outcomes. Arch Intern Med 166:2314–2321

    PubMed  Article  Google Scholar 

  23. 23.

    Goodwin PJ, Leszcz M, Ennis M, et al (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726

    PubMed  Article  Google Scholar 

  24. 24.

    Hem E, Loge JH, Haldorsen T, Ekeberg Ø (2004) Suicide risk in cancer patients from 1960 to 1999. J Clin Oncol 22:4209–4216

    PubMed  Article  Google Scholar 

  25. 25.

    Holland JC, Romano SJ, Heiligenstein JH, et al (1998) A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 7:291–300

    PubMed  Article  Google Scholar 

  26. 26.

    Hopko DR, Bell JL, Armenta ME, et al (2008) The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 26:31–51

    PubMed  Article  Google Scholar 

  27. 27.

    Kissane DW, Grabsch B, Clarke DM, et al (2007) Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 16:277–286

    PubMed  Article  Google Scholar 

  28. 28.

    Lee KC, Ray GT, Hunkeler EM, et al (2007) Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 48:205–210

    PubMed  Article  Google Scholar 

  29. 29.

    Li M, Fitzgerald P, Rodin G (2012) Evidence-based treatment of depression in patients with cancer. J Clin Oncol 30:1187–1196

    PubMed  Article  Google Scholar 

  30. 30.

    Lloyd-Williams M, Dennis M, Taylor F (2004) A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 18:558–563

    PubMed  Article  Google Scholar 

  31. 31.

    Misono S, Weiss NS, Fann JR, et al (2008) Incidence of suicide in persons with cancer. J Clin Oncol 26:4705–4707

    Article  Google Scholar 

  32. 32.

    Mitchell AJ (2007) Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 25:4670–4681

    PubMed  Article  Google Scholar 

  33. 33.

    Mitchell AJ (2010) Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. JNCCN 8:487–494

    PubMed  Google Scholar 

  34. 34.

    Mitchell AJ, Chan M, Bhati H, et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interviewbased studies. Lancet Oncol 12:160–174

    PubMed  Article  Google Scholar 

  35. 35.

    Mitchell AJ, Meader N, Davies E (2012) Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord 140:149–160

    PubMed  Article  Google Scholar 

  36. 36.

    Mitchell AJ, Lord K, Symons P (2012) Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord 140:137–148

    Article  Google Scholar 

  37. 37.

    Mitchell AJ (2013) Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncologica 52:216–224

    PubMed  Article  Google Scholar 

  38. 38.

    Möller HJ (2008) Do SSRIs or antidepressant in general increase suicidality? Eur Arch Psychiatry Clin Neurosci 258(Suppl 3):3–23

    PubMed  Article  Google Scholar 

  39. 39.

    Montazeri A, Jarvandi S, Haghighat S, et al (2001) Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns 45:195–198

    PubMed  Article  Google Scholar 

  40. 40.

    Montgomery C, Lydon A, Lolyd K (1999) Psychological distress among cancer patients and informed consent. J Psychosom Res 46:241–245

    PubMed  Article  Google Scholar 

  41. 41.

    Musselman DL, Somerset WI, Guo Y, et al (2006) A doubleblind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 67:288–296

    PubMed  Article  Google Scholar 

  42. 42.

    Osborn RL, Demoncada AC, Feuerstein M (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36:13–34

    PubMed  Article  Google Scholar 

  43. 43.

    Pampallona S, Bollini P, Tibaldi G, et al (2004) Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 61:714–719

    PubMed  Article  Google Scholar 

  44. 44.

    Parker PA, Baile WF, de Moor Cd, Cohen L (2003) Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology 12(2):183–193

    PubMed  Article  Google Scholar 

  45. 45.

    Pasquini M, Biondi M (2007) Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health 3:2

    PubMed Central  PubMed  Article  Google Scholar 

  46. 46.

    Pezzella G, Moslinger-Gehmayr R, Contu A (2001) Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 70:1–10

    PubMed  Article  Google Scholar 

  47. 47.

    Pitceathly C, Maguire P (2003) The psychological impact of cancer on patients’ partners and other key relatives: a review. Eur J Cancer 39:1517–1524, 1532

    PubMed  Article  Google Scholar 

  48. 48.

    Prieto JM, Blanch J, Atala J, et al (2002) Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 20:1907–1917

    PubMed  Article  Google Scholar 

  49. 49.

    Prieto JM, Atala J, Blanch J, et al (2005) Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 23(25):6063–6071

    PubMed  Article  Google Scholar 

  50. 50.

    Rasic DT, Belik SL, Bolton JM, et al (2008) Cancer, mental disorders, suicidal ideation and attempts in a large community sample. Psychooncology 17:660–667

    PubMed  Article  Google Scholar 

  51. 51.

    Rayner L, Price A, Evans A, et al (2010) Antidepressants for depression in physically ill people. Cochrane Database Syst Rev (3):CD007503

    PubMed  Google Scholar 

  52. 52.

    Rodin G, Lloyd N, Katz M, et al (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15:123–136

    PubMed  Article  Google Scholar 

  53. 53.

    Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: a metaanalysis. Cancer 115:5349–5361

    PubMed  Article  Google Scholar 

  54. 54.

    Sheard T, Maguire P (1999) The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 80:1770–1780

    PubMed Central  PubMed  Article  Google Scholar 

  55. 55.

    So WK, Marsh G, Ling WM, et al (2009) The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum 36:205–214

    Article  Google Scholar 

  56. 56.

    Spiegel D, Sands S, Koopman C (1994) Pain and depression in patients with cancer. Cancer 74(9):2570–2578

    PubMed  Article  Google Scholar 

  57. 57.

    Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282

    PubMed  Article  Google Scholar 

  58. 58.

    Stanton AL (2005) How and for whom? Asking questions about the utility of psychosocial interventions for individuals diagnosed with cancer. J Clin Oncol 23:4818–4820

    PubMed  Article  Google Scholar 

  59. 59.

    Watson M, Homewood J, Haviland J, Bliss JM (2005) Influence of psychological response on breast cancer survival: 10-year followup of a population-based cohort. Eur J Cancer 41(12):1710–1714

    PubMed  Article  Google Scholar 

  60. 60.

    Wedding U, Koch A, Röhrig B, et al (2007) Requestioning depression in patients with cancer: contribution of somatic and affective symptoms to Beck’s Depression Inventory. Ann Oncol 18:1875–1881

    PubMed  Article  Google Scholar 

  61. 61.

    Wong-Kim EC, Bloom JR (2005) Depression experienced by young women newly diagnosed with breast cancer. Psychooncology 14:564–573

    PubMed  Article  Google Scholar 

  62. 62.

    Yap KY, Tay WL, Chui W, Chan A (2011) Clinically relevant drug interactions between anticancer drugs and psychotropic agents. Eur J Cancer Care 20:6–32

    Article  Google Scholar 

  63. 63.

    Yousaf U, Christensen ML, Engholm G, Storm HH (2005) Suicides among Danish cancer patients 1971–1999. Br J Cancer 92:995–1000

    PubMed Central  PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to S. Dauchy.

About this article

Cite this article

Dauchy, S., Dolbeault, S., Reich, M. et al. Repérage et traitement de la dépression en cancérologie. Psycho Oncologie 7, 217–227 (2013). https://doi.org/10.1007/s11839-013-0438-y

Download citation

Mots clés

  • Dépression
  • Oncologie
  • Repérage
  • Facteurs de risque
  • Traitement médicamenteux
  • Approches non médicamenteuses
  • Conduite à tenir

Keywords

  • Oncology
  • Depression
  • Risk factors
  • Screening
  • Psychotrops
  • Psychotherapy
  • Clinical guidelines